Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cediranib food effect and dosing in advanced solid tumours
NCT00306891Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Jun 2006
- Primary completion
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cediranib in solid tumor (advanced stage), sponsored by AstraZeneca. Started Jun 2006; status: completed.
02
Drugs
cediranib
03
Conditions
solid tumor (advanced stage)
Beyond the preview
Go deeper on NCT00306891.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00306891.